Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04565951 · ClinicalTrials.gov registry record · NA

Increasing Help-Seeking Behavior Among Transitioning Veterans at Risk for Suicide With Online Gatekeeper Training

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
281
Enrollment target

NCT04565951: Completed NA study, sponsored by VA Office of Research and Development.

NCT04565951 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 281 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04565951, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
281 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the feasibility and acceptability of a gatekeeper training called VA S.A.V.E. which was developed through a partnership between the VA and the PsychArmor Training Institute. Gatekeeper training teaches "gatekeepers" skills in how to identify a person with suicide risk, inquire about suicidal thoughts, and help make a connection to professional treatment. VA S.A.V.E. is a brief, novel online gatekeeper training that was created and designed specifically for Veterans and their family and friends. In this study, the investigators will recruit Veterans who have recently transitioned out of the military, as well as their family and friends. Participants in the study will be asked to complete a survey, watch the VA S.A.V.E. training, and complete several follow-up surveys over six months. A small subset of participants will also be invited to participate in an interview.

Primary Outcome

Number enrolled; proportion of eligible who enroll

Interventions

  • BEHAVIORAL VA S.A.V.E.
  • BEHAVIORAL Sham intervention

Trial Details

FieldValue
Enrollment Target 281 participants
Start Date 2021-03-13
Est. Completion 2021-12-14
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT04565951 record still lists

NCT04565951 is an interventional study that assigns participants to a tested intervention. The registered 281 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 2 interventions - of which VA S.A.V.E. is the first listed.

NCT04565951 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04565951 about?

NCT04565951 is a clinical study titled "Increasing Help-Seeking Behavior Among Transitioning Veterans at Risk for Suicide With Online Gatekeeper Training". The purpose of this study is to evaluate the feasibility and acceptability of a gatekeeper training called VA S.A.V.E. which was developed through a partnership between the VA and the PsychArmor Training Institute. Gatekeeper training teaches "gatekeepers" skills in how to identify a person with sui...

What is the current status of trial NCT04565951?

This trial is currently completed. It is a NA study. The enrollment target is 281 participants. The study started on 2021-03-13. Estimated completion is 2021-12-14.

What interventions are being tested in trial NCT04565951?

The interventions under investigation include: VA S.A.V.E. (BEHAVIORAL), Sham intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04565951?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04565951's enrollment target sits among peer trials

281 380th of 2000 higher than 1,621 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04521231 · 281 participants · Phase 1

    A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

  • NCT06190730 · 281 participants · NA

    REmote Symptom COllection to improVE postopeRative Care

  • NCT02860364 · 282 participants · NA

    Comparing Hypothermic Temperatures During Hemiarch Surgery

  • NCT04867395 · 282 participants · NA

    A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04565951, the US trial registry maintained by the National Library of Medicine. NCT04565951 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.